𝔖 Bobbio Scriptorium
✦   LIBER   ✦

3.054 THE PREVALENCE OF CANCER IN PATIENTS WITH PARKINSON'S DISEASE WHO ARE CARRIERS OF THE G2019S MUTATION IN THE LRRK2 GENE

✍ Scribed by A. Mirelman; A. Thaler; T. Gurevich; A. Shkedy; A. Bar Shira; A. Orr-Urtreger; N. Giladi

Book ID
117755157
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
60 KB
Volume
18
Category
Article
ISSN
1353-8020

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The G2019S LRRK2 mutation in Brazilian p
The G2019S LRRK2 mutation in Brazilian patients with Parkinson's disease: Phenotype in monozygotic twins
✍ Renato P. Munhoz; Yosuke Wakutani; Connie Marras; Helio A. Teive; Salmo Raskin; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 163 KB

## Abstract Mutations in the Leucine‐Rich Repeat Kinase 2 gene (__LRRK2__) are mainly responsible for idiopathic Parkinson's disease (PD) with either a dominant pattern of transmission or a sporadic occurrence due to the reduced penetrance. A majority of __LRRK2__ kindreds demonstrate an extremely

Frequency and phenotypes of LRRK2 G2019S
Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease
✍ Roberta Marongiu; Daniele Ghezzi; Tamara Ialongo; Francesco Soleti; Antonio Elia πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 74 KB

To evaluate the frequency of the LRRK2 G2019S mutation in Italy, we tested 1,072 probands with Parkinson's disease (PD; 822 sporadic and 250 familial): 20 patients (1.9%) carried the G2019S mutation, 11 patients (1.3%) were sporadic, and 9 (4.3%) had a positive family history. Considering only proba